Free Newsletter
Cambrex automates plant processes
An upgrade from manual monitoring and recording practices to automated systems has earned Cambrex Profarmaco a 4 percent increase in overall equipment effectiveness.
The Milan, Italy-based drugmaker, a producer of 70 active ingredients used in generic drugs, has implemented Emerson Process Management's PlantWeb digital plant architecture. The growing company's goal was to speed process validation and simplify batch traceability while maintaining regulatory compliance. It needed precise control of process variables and automated record-keeping.
The PlantWeb architecture includes the Delta V automated system for precision process control and predictive maintenance. PlantWeb's AMS software uses predictive intelligence to optimize equipment availability and performance.
Temperature and pressure instruments, analytical pH and conductivity meters, and mass flowmeters also are part of the package. The system maintains Cambrex's 21 CFR Part 11 compliance. And it improves the company's data traceability and process reproducibility while capturing data for GMP documentation.
- see the announcement
Related Article:
Regulator's plans require automation
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: